Characteristics of contemporary drug clinical trials regarding the treatment of non-alcoholic steatohepatitis-Reference-Cited by-同舟云学术

Characteristics of contemporary drug clinical trials regarding the treatment of non-alcoholic steatohepatitis

Published:2024-01 Issue:1 Volume:18 Page:102921
ISSN:1871-4021
Container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews
language:en
Short-container-title:Diabetes & Metabolic Syndrome: Clinical Research & Reviews

Author:

Zhao Shanshan^ORCID,Zhang Lan,Zhao Junzhe,Kota Vishnu Goutham,Venkat Kartik Mitra,Tasnim Farah,Yu Hanry

Publisher

Elsevier BV

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference31 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

2. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;Vernon;Aliment Pharmacol Ther,2011

3. Therapeutic pipeline in nonalcoholic steatohepatitis;Vuppalanchi;Nat Rev Gastroenterol Hepatol,2021

4. NAFLD: a multisystem disease;Byrne;J Hepatol,2015

5. Controversies and opportunities in the use of inflammatory markers for diagnosis or risk prediction in fatty liver disease;Lambrecht;Front Immunol,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric metabolic (dysfunction)-associated fatty liver disease: current insights and future perspectives;Hepatology International;2024-06-16

2. The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-11

3. Highlights of the current issue;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-01